Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel effects on plasma adenosine in healthy volunteers
ChiCTR1800019333Phase 4Recruiting
- Sponsor
- Changhai Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor and clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Changhai Hospital. Primary endpoints: Plasma adenosine concentration, Adenosine uptake by red blood cells and 1 more. Started Nov 2018; status: recruiting.
02
Drugs
ticagrelorclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800019333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019333.